Anne Nagengast Johnson

Insider Reports History

Entity
Individual
Location
C/O Atai Life Sciences N.V., Wallstrasse 16, Berlin, Germany
Signature
/s/ Ryan Barrett, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Nagengast Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ATAI Life Sciences N.V. Chief Financial Officer Common Shares 73.6K $136K $1.85 Apr 2, 2024 Direct
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 550K Mar 13, 2024 Direct
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 115K Oct 4, 2024 Direct
ATAI Life Sciences N.V. Chief Financial Officer Restricted Stock Units 100K Mar 14, 2024 Direct

Insider Reports Filed by Anne Nagengast Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATAI ATAI Life Sciences N.V. Oct 4, 2024 4 $0 4 Oct 4, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Apr 2, 2024 1 -$50.7K 4 Apr 4, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Mar 13, 2024 3 $0 4 Mar 15, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. May 10, 2023 0 $0 3 May 19, 2023 Chief Accounting Officer